{"organizations": [], "uuid": "82e25d30061d4f7ce9e384615a5d6ceae8995917", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180122.html", "section_title": "Archive News &amp; Video for Monday, 22 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zhejiang-jiuzhou-pharmaceutical-se/brief-zhejiang-jiuzhou-pharmaceutical-sees-fy-2017-net-profit-up-30-pct-to-50-pct-idUSL4N1PH2WY", "country": "US", "domain_rank": 408, "title": "BRIEF-Zhejiang Jiuzhou Pharmaceutical sees FY 2017 net profit up 30 pct to 50 pct", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.339, "site_type": "news", "published": "2018-01-22T15:52:00.000+02:00", "replies_count": 0, "uuid": "82e25d30061d4f7ce9e384615a5d6ceae8995917"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zhejiang-jiuzhou-pharmaceutical-se/brief-zhejiang-jiuzhou-pharmaceutical-sees-fy-2017-net-profit-up-30-pct-to-50-pct-idUSL4N1PH2WY", "ord_in_thread": 0, "title": "BRIEF-Zhejiang Jiuzhou Pharmaceutical sees FY 2017 net profit up 30 pct to 50 pct", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-zhejiang jiuzhou pharmaceutical", "sentiment": "negative"}, {"name": "zhejiang jiuzhou pharmaceutical co ltd", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 22 (Reuters) - Zhejiang Jiuzhou Pharmaceutical Co Ltd\n* Says it sees net profit for FY 2017 to increase by 30 percent to 50 percent\n* Says the net profit of FY 2016 was 111.5 million yuan\n* Comments that increased gross profit rate of CDMO business as well as increased income of API business as main reasons for the forecast\nSource text in Chinese: goo.gl/uuZE1e\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/uuZE1e", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-22T15:52:00.000+02:00", "crawled": "2018-01-23T18:07:01.000+02:00", "highlightTitle": ""}